Primary diastolic heart failure

American Journal of Geriatric Cardiology

Volumn 11, Issue 3, 2002, Pages 178-189

  Chatterjee, Kanu ^a  

^a UCSF Medical Center at Parnassus   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; AMIODARONE; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRAIN NATRIURETIC PEPTIDE; CALCIUM CHANNEL BLOCKING AGENT; DIGITALIS; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PHOSPHODIESTERASE INHIBITOR; PHOSPHOLAMBAN; VERAPAMIL;

AGED; AGING; BETA ADRENERGIC RECEPTOR BLOCKING; CALCIUM ANTAGONISM; CLINICAL TRIAL; CONSTRICTIVE PERICARDITIS; DIGITALIZATION; DIURETIC THERAPY; DRUG EFFECT; ECHOCARDIOGRAPHY; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FILLING; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE FIBROSIS; HEART RATE; HEART SCINTISCANNING; HEART VENTRICLE ARRHYTHMIA; HEMODYNAMICS; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; HYPOTENSION; INCIDENCE; KIDNEY FAILURE; PREVALENCE; PROGNOSIS; REVIEW; RISK FACTOR; SYMPTOMATOLOGY; TACHYCARDIA; VALVULAR HEART DISEASE; VASODILATATION;

EID: 0036249714     PISSN: 10767460     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1076-7460.2002.00051.x     Document Type: Review

References (34)

1. Diastolic heart failure: Current treatment options in cardiovascular medicine
2. Diastolic ventricular failure: A clinician's approach
3. Diastolic failure: Pathophysiology and therapeutic implications
4. Diastolic dysfunction in congestive heart failure
5. Diagnosis and treatment of heart failure based on left ventricular systolic and diastolic dysfunction
6. Defining diastolic heart failure: A call for standardized diagnostic criteria
7. Defining diastolic dysfunction
8. The natural history of congestive heart failure: The Framingham study
9. Congestive heart failure in subjects with normal versus reduced ejection fraction: Prevalence and mortality in a population based cohort
10. Long-term outcome in patients with congestive heart failure and intact systolic left ventricular performance
11. Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction
12. Plasma brain natriuretic peptide concentration as a useful predictor of mortality and morbidity in patients with diastolic heart failure
13. A rapid bedside test for brain natriuretic peptide accurately delineates both systolic and diastolic dysfunction in patients referred for echocardiography
14. Mechanisms, diagnosis, and treatment of diastolic heart failure
15. Heart failure associated with preserved systolic function: A common and costly clinical entity
16. Prevalence, clinical features, and prognosis of diastolic heart failure: An epidemiologic perspective
17. Evolving trends in the epidemiologic factors of heart failure: Rationale for preventive strategies and comprehensive disease management
18. Congestive heart failure in the community, a study of all incident cases in Olmsted County, Minnesota, in 1991
19. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
20. Age-associated changes in the cardiovascular system in the absence of cardiovascular disease
21. Diastolic heart failure in the community: Underlying cardiovascular diseases and precipitative factors
22. Autopsy findings in patients with diastolic versus systolic heart failure
23. Heart failure with preserved systolic function in African-Americans: The rule of diabetes mellitus and obesity
24. Factors influencing survival of patients with diastolic heart failure in Olmstead County, MN, in 1996-97
25. New onset heart failure in the outpatient setting: Characteristics and outcomes of patients with low and preserved EF
26. Prognosis of congestive heart failure in elderly patients with normal versus abnormal left ventricular systolic function associated with coronary artery disease
27. Diastolic heart failure: Diagnosis, mechanisms, and treatment
28. The natural history of isolated left ventricular diastolic dysfunction
29. Improvement in indexes of diastolic performance in patients with congestive heart failure treated with milrinone
30. The effect of digoxin on mortality and morbidity in patients with heart failure
31. Losartan improves exercise intolerance in patient with diastolic dysfunction and hypertensive response to exercise
32. Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance
33. Verapamil-induced improvement in left ventricular filling and increased exercise tolerance in patients with hypertrophic cardiomyopathy: Short- and long-term results
34. Pathological hypertrophy and cardiac interstitium: Fibrosis and renin-angiotensin-aldosterone system